Bridgewater Associates LP Has $47,000 Position in agilon health, inc. (NYSE:AGL)

Bridgewater Associates LP lowered its holdings in shares of agilon health, inc. (NYSE:AGL) by 79.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,539 shares of the company’s stock after selling 92,761 shares during the quarter. Bridgewater Associates LP’s holdings in agilon health were worth $47,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Charles Schwab Investment Management Inc. lifted its stake in agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after acquiring an additional 1,498,524 shares in the last quarter. JPMorgan Chase & Co. raised its stake in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after acquiring an additional 1,083,492 shares during the period. Alberta Investment Management Corp bought a new stake in shares of agilon health during the 4th quarter worth about $1,564,000. Renaissance Technologies LLC boosted its holdings in shares of agilon health by 155.1% during the fourth quarter. Renaissance Technologies LLC now owns 463,300 shares of the company’s stock worth $880,000 after acquiring an additional 281,700 shares during the period. Finally, Vanguard Group Inc. grew its holdings in agilon health by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after buying an additional 272,787 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Cowen restated a “hold” rating on shares of agilon health in a research report on Tuesday, April 15th. Sanford C. Bernstein raised shares of agilon health from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. TD Cowen raised their price objective on agilon health from $3.50 to $6.00 and gave the company a “hold” rating in a report on Tuesday, April 15th. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Finally, Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, agilon health currently has a consensus rating of “Hold” and an average price target of $4.60.

agilon health Price Performance

Shares of AGL opened at $4.02 on Monday. The stock has a market cap of $1.66 billion, a P/E ratio of -4.28 and a beta of 0.38. The business’s fifty day moving average is $4.14 and its 200 day moving average is $3.11. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $7.73.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.